Holy Hormones Journal: In my humble opinion – it is not the numbers or percentage – it is that it occurs. And unless we know why – what the co-factors were for the women who were at risk for breast cancer while on HRT – we should be staying away from it. PERIOD. However, the study referenced in this article did cite that HRT increases breast cancer risk by 170% – and that small number of 2% of women in the study who developed breast cancer actually translated to 775. That is a significant number.
Living with our endocrine rhythm – understanding our mind, moods, and hormone cycle – honoring our bodies instead of feeling shamed by them – and eliminating the environmental endocrine disruptors in our homes – and supplementing our diets with micronutrients all leads to a healthy neuro-endocrine-immune system instead of being a hormone mess by the time we transition into menopause.
Although the combined HRT is thought to be riskier than estrogen HRT – let us not forget that unchecked estrogen has also been linked to breast cancer. As well as mammograms. My guess is that the combination HRT was riskier because of the interaction of the two synthetic hormones. It is all a medical experiment… and it is being done to our bodies.
British study finds risk of breast cancer nearly tripled by combined HRT
2% of women monitored for six years got breast cancer – and they were 2.7 times more likely to contract it if they were on combined HRT than if they were not
Women who rely on the most commonly used form of hormone replacement therapy are roughly three times more likely to develop breast cancer than those who do not use it, according to a study whose results suggest the risk of illness has been previously understated.
Those using the combined HRT therapy, a combination of oestrogen and progestogen, were running a risk 2.7 times greater than non-users, according to a study by scientists at the Institute of Cancer Research (ICR) in London.
Previous investigations may have underestimated the increased risk by up to 60%, the study added.
Anthony Swerdlow, professor of epidemiology at the ICR, said: “What we found is that the risks with combined HRT are larger than most of the literature would suggest.”
The study’s leaders added that HRT is an individual choice but one for which accurate information is essential.
An estimated one in 10 women in their 50s use HRT to deal with menopausal symptoms including hot flushes, night sweats, insomnia, mood swings and tiredness.
The treatment is effective but controversial because studies published in 2002 and 2003 have previously suggested there is also link with breast cancer. Those findings led to a halving of the numbers of women taking the drugs.
In November an NHS watchdog, the National Institute for Health and Care Excellence (Nice), sought to reassure women about the safety of the treatment, which replaces depleted oestrogen and – in combined HRT – progestogen to alleviate symptoms.